SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: alan laValley who wrote (13541)8/17/1998 11:42:00 PM
From: VLAD  Read Replies (1) | Respond to of 23519
 
al,

They simply got too cocky and over confident after going from years of losing money to suddenly netting over $30 million on a product whose demand was higher than their capacity to produce it. This very scenario gave vivus management the mentality that they could rely on a massive cash flow from MUSE sales (thus the adverstising/rental sales force/stock buy back wastes) and only needed to increase their capacity to produce MUSE to be successful.

They made the crucial error of assuming that Viagra initially would decrease sales in Q2 and Q3 but would eventually help sales via awareness.

We now all know that they totally misjudged just how much Viagra would effect MUSE sales in Q2 and Q3.

Fact of the matter is that they indeed did need to expand their capacity to produce MUSE but they ignored the Viagra cloud and instead of conserving cash for the rainy Viagra launch day, they blew almost the entire wad on things that were better never spent on.

And we can't just blame the management because it was the board of directors that approved the stock buy back. There was nothing wrong with approving the buy back but spending all the money in 2 quarters was foolish instead of conserving the cash for times like now.

Anyway the damage is done and over now. There still is an opportunity for Vivus to gain the Viagra failures. There is but one way this can be done.

Domestic Partner! ASAP!